EKSO:NASDAQ
Ekso Bionics Holdings Inc
US$ ११.१६
arrow_downward
-७.१२%(-०.८६) 1D
मे १, १५:०९:५० GMT-४ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EKSO...
Open
US$ १२.२६
High
US$ १२.३१
Low
US$ १०.९८
Mkt. cap
३.९७ करोड
Avg. vol.
७३.११ हजार
Volume
२९.६२ हजार
52-wk high
US$ १३.५०
52-wk low
US$ २.७५
EPS
-US$ ४.९१
Beta
०.७८
Shares outstanding
३५.६३ लाख
No. of employees
५०
News stories
From sources across the web
kare11.com
·
२ दिन पहिले
Ekso Bionics: Q1 Earnings Snapshot
Profile
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk.
Ekso Bionics currently focuses in the health and industrial sectors.
The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
About Ekso Bionics Holdings Inc
CEOScott Davis
Employees५०
Founded२००५
HeadquartersSan Rafael, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websiteeksobionics.com
AI content may include mistakes. Learn more